Aldeyra Therapeutics, Inc. (ALDX) stock
ALDXNasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.64+0.01 (+2.17%)
Close on Nov 13, 2026Market cap $38.84MP/E –Yield –
Aldeyra Therapeutics enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Aldeyra Therapeutics's enterprise value was -$5.80M on Nov 11, 2026, against $269.59M a year earlier. Over the last 5 years it ranged from -$84.04M to $423.04M, with a median of $132.38M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | -$5.80M | -102.3% |
| 2025 | Dec 31, 2025 | $251.55M | +26.0% |
| 2024 | Dec 31, 2024 | $199.69M | +148.0% |
| 2023 | Dec 29, 2023 | $80.53M | -64.3% |
| 2022 | Dec 30, 2022 | $225.55M | – |
| 2021 | Dec 31, 2021 | -$71.28M | -137.2% |
| 2020 | Dec 31, 2020 | $191.53M | +99.6% |
| 2019 | Dec 31, 2019 | $95.97M | -39.1% |
| 2018 | Dec 31, 2018 | $157.55M | +60.4% |
| 2017 | Dec 29, 2017 | $98.23M | +82.0% |
| 2016 | Dec 30, 2016 | $53.98M | +47.8% |
| 2015 | Dec 31, 2015 | $36.51M | +16.7% |
| 2014 | Dec 31, 2014 | $31.28M | – |
See a number that looks wrong?